TriSalus Life Sciences In... (TLSI)
NASDAQ: TLSI
· Real-Time Price · USD
5.44
0.25 (4.82%)
At close: Jun 16, 2025, 3:59 PM
5.51
1.29%
After-hours: Jun 16, 2025, 04:04 PM EDT
4.82% (1D)
| Bid | 5.07 |
| Market Cap | 205.84M |
| Revenue (ttm) | 32.14M |
| Net Income (ttm) | -27.21M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -4.95 |
| Forward PE | -32.18 |
| Analyst | Buy |
| Ask | 5.7 |
| Volume | 24,392 |
| Avg. Volume (20D) | 49,734 |
| Open | 5.22 |
| Previous Close | 5.19 |
| Day's Range | 5.22 - 5.55 |
| 52-Week Range | 3.50 - 6.14 |
| Beta | 0.47 |
About TLSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TLSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-10.89%
TriSalus Life Sciences shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago · seekingalpha.com
TriSalus Life Sciences: Optimistic Guidance For 2025, But There Are Still RisksTriSalus Life Sciences aims to achieve positive cash flow by 2025, driven by expanding sales of their TriNav system and reducing operating expenses. The PERIO-03 trial for nelitolimod, a potential tre...
2 months ago · seekingalpha.com
TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call TranscriptTriSalus Life Sciences, Inc. (NASDAQ:TLSI ) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Company Participants Jeremy Feffer - Managing Director, LifeSci Advisors Mary Szela - President &...
